Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

ARS Pharmaceuticals Inc (SPRY) Q3 2024 Earnings Call Highlights: Strong Cash Position and NEPHI ... [Yahoo! Finance]

ARS Pharmaceuticals, Inc. (SPRY) 
Company Research Source: Yahoo! Finance
Total Operating Expenses: $23.8 million in Q3 2024. SG&A Expenses: $19.3 million, expected to increase in Q4 2024. GAAP Net Loss: $19.1 million or $0.20 per share in Q3 2024. Cash, Cash Equivalents, and Short-term Investments: $204.6 million at the end of Q3 2024. Pro Forma Cash Position: $349.6 million including $145 million upfront payment from ALK. Warning! GuruFocus has detected 3 Warning Sign with SPRY. Release Date: November 13, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript ARS Pharmaceuticals Inc ( NASDAQ:SPRY ) received approval for NEPHI 2 mg in both the United States and Europe, marking it as the first needle-free epinephrine product for allergic reactions. The company has launched NEPHI in the U.S., with strong support and enthusiasm from patients, caregivers, and the medical community. A strategic licensing agreement with AOK has been established, expanding NEPHI's reach to Europe, Canada, and Show less Read more
Impact Snapshot
Event Time:
SPRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SPRY alerts
Opt-in for
SPRY alerts

from News Quantified
Opt-in for
SPRY alerts

from News Quantified